L. Mastromauro

Incobotulinumtoxina (Xeomin®) Versus Onabotulinumtoxina (Botox®): Evaluation of Clinical Onset of Action with Rating Scales and Electroneurography

P. Trerotoli, L. Mastromauro, E. Romanelli, 2015 .

Efficacy of Incobotulinumtoxin Type A (Xeomin ® ) in the Management of Sialorrhea in Neurodegenerative Diseases

P. Fiore, M. Megna, L. Mastromauro, 2017 .

Extracorporeal shockwave therapy versus exercise program in patients with low back pain: short-term results of a randomised controlled trial.

B. Moretti, G. Maccagnano, A. Notarnicola, 2018, Journal of biological regulators and homeostatic agents.

Motor Recovery of Lower Limbs in Cerebral Palsy with Botulinum Toxin and Physioteraphy

L. Mastromauro, 2017 .